Brief: Brii Biosciences Posts FY Revenue RMB617,000
22/03/2024 12:53
March 22 (Reuters) - Brii Biosciences Ltd 2137.HK :
* FY REVENUE RMB617,000 VERSUS RMB51.6 MILLION
* FY LOSS ATTRIBUTABLE RMB174.8 MILLION VERSUS LOSS RMB484.3
MILLION
Further company coverage: 2137.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR